Investigating the anti-allergic activity of Phyllanthus niruri via MALT1 protease inhibition: An in silico approach
DOI:
https://doi.org/10.46542/pe.2023.234.196202Keywords:
Anti-allergic agent, Immune system, In silico, MALT1 protease, Phyllantus niruriAbstract
Background: Allergic inflammation is a condition caused by complex interactions between several inflammatory cells in the body. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) is a cysteine protease that bridges innate and adaptive immune responses in allergic inflammation. MALT1 protease inhibition is a potential strategy for controlling IgE-mediated allergic disease. P. niruri is a medicinal plant with anti-allergic properties.
Objective: This study aimed to evaluate the anti-allergic activity of P. niruri secondary metabolites against MALT1 protease through in silico approach.
Method: Physicochemical properties and drug-likeness evaluation were determined using SwissADME. The toxicity properties prediction was analysed using pkCSM. AutoDock Vina was used to evaluate the best binding energy of the compounds against the receptor (PDB ID: 3V4O and 4I1R). Visualisation was obtained using Biovia discovery studio visualiser.
Result: Docking analysis showed that ten of 21 compounds have lower binding affinity than the native ligand and reference drugs at the 3V4O receptor. At the 4I1R receptor, only three compounds have a lower binding affinity than its native ligand, but only one compound has a lower binding affinity than all reference drugs.
Conclusion: Several P. niruri secondary metabolites were potentially predicted to be developed as MALT1 protease inhibitory agents.
References
Abd Rani, N. Z., Lam, K. W., Jalil, J., Mohamad, H. F., Mat Ali, M. S., & Husain, K. (2021). Mechanistic studies of the antiallergic activity of Phyllanthus amarus Schum. & Thonn. and Its Compounds. Molecules, 26(3), 695. https://doi.org/10.3390/molecules26030695
Alfano, D. N., Klei, L. R., Klei, H. B., Trotta, M., Gough, P. J., Foley, K. P., Bertin, J., Sumpter, T. L., Lucas, P. C., & McAllister-Lucas, L. M. (2020). MALT1 Protease Plays a Dual Role in the allergic response by acting in both mast cells and endothelial cells. Journal of immunology, 204(9), 2337–2348. https://doi.org/10.4049/jimmunol.1900281
Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016). BDDCS, the rule of 5 and drugability. Advanced drug delivery reviews, 101, 89–98. https://doi.org/10.1016/j.addr.2016.05.007
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. Accessed on March 30, 2023.: http://www.swissadme.ch/,
Demeyer, A., Staal, J., & Beyaert, R. (2016). Targeting MALT1 proteolytic activity in immunity, inflammation and disease: good or bad? Trends in molecular medicine, 22(2), 135–150. https://doi.org/10.1016/j.molmed.2015.12.004
Doak, B. C., Over, B., Giordanetto, F., & Kihlberg, J. (2014). Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. Chemistry & biology, 21(9), 1115–1142.https://doi.org/10.1016/j.chembiol.2014.08.013
Galli, S. J., Tsai, M., & Piliponsky, A. M. (2008). The development of allergic inflammation. Nature, 454(7203), 445–454. https://doi.org/10.1038/nature07204
Hamp, I., O'Neill, T. J., Plettenburg, O., & Krappmann, D. (2021). A patent review of MALT1 inhibitors (2013-present). Expert opinion on therapeutic patents, 31(12), 1079–1096. https://doi.org/10.1080/13543776.2021.1951703
Jantan, I., Haque, M. A., Ilangkovan, M., & Arshad, L. (2019). An insight into the modulatory effects and mechanisms of action of Phyllanthus species and their bioactive metabolites on the immune system. Frontiers in pharmacology, 10, Article 878. https://doi.org/10.3389/fphar.2019.00878
Kartini, K., Wulandari, W. A., Jayani, N. I. E., & Setiawan, F. (2021). TLC-based fingerprinting for Phyllanthus niruri from diverse geographical origins in East and Central Java Indonesia. IOP Conference Series: Earth and Environmental Science, 948(1). https://doi.org/10.1088/1755-1315/948/1/012003
KnapSack Family. Accessed in: http://www.knapsackfamily.com/KNApSAcK_Family/, on March 30, 2023.
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced drug delivery reviews, 46(1-3), 3–26. https://doi.org/10.1016/s0169-409x(00)00129-0
Marhaeny, H. D., Widyawaruyanti, A., Widiandani, T., Fuad Hafid, A., & Wahyuni, T. S. (2021). Phyllanthin and hypophyllanthin, the isolated compounds of Phyllanthus niruri inhibit protein receptor of corona virus (COVID-19) through in silico approach. Journal of basic and clinical physiology and pharmacology, 32(4), 809–815. https://doi.org/10.1515/jbcpp-2020-0473
Marhaeny, H. D., Pratama, Y. A., Rohmah, L., Kasatu, S. M., Miatmoko, A., & Khotib, J. (2023) Development of gastro-food allergy model in shrimp allergen extract-induced sensitised mice promotes mast cell degranulation. Journal of Public Health in Africa, 14(s1), 2512. https://doi.org/10.4081/jphia.2023.2512
Mukherjee, M., & Gupta, S. (2018). Evaluation of acute toxicity and anti-asthmatic activity of Phyllanthus niruri L. leaves extracts. Asian Journal of Pharmacy and Pharmacology, 4(5), 615–619. https://doi.org/10.31024/ajpp.2018.4.5.11
National Center for Biotechnology Information - National Library Medicine: PubChem. Accessed on March 30, 2023. https://pubchem.ncbi.nlm.nih.gov/:
Pawankar R. (2014). Allergic diseases and asthma: A global public health concern and a call to action. The World Allergy Organisation journal, 7(1), Article 12. https://doi.org/10.1186/1939-4551-7-12
Paithankhar, V. V., Raut, K. S., Charde, R. M., & Vyas, J. V. (2011). Phyllanthus niruri: A magic Herb. Research in Pharmacy, 1(4), 1–9.
Pires, D. E. V., Blundell, T., L., & Ascher, D. B. (2015). pkCSM: predicting small-molecule pharmacokinetic properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. Accessed on March 30, 2023. https://biosig.lab.uq.edu.au/pkcsm/prediction
Wai, C., Leung, N., Leung, A., Wong, G., & Leung, T. F. (2021). Seafood allergy in Asia: Geographical specificity and Beyond. Frontiers in allergy, 2, Article 676903. https://doi.org/10.3389/falgy.2021.676903
Wanat K. (2020). Biological barriers, and the influence of protein binding on the passage of drugs across them. Molecular biology reports, 47(4), 3221–3231. https://doi.org/10.1007/s11033-020-05361-2
Wiesmann, C., Leder, L., Blank, J., Bernardi, A., Melkko, S., Decock, A., D'Arcy, A., Villard, F., Erbel, P., Hughes, N., Freuler, F., Nikolay, R., Alves, J., Bornancin, F., & Renatus, M. (2012). Structural determinants of MALT1 protease activity. Journal of molecular biology, 419(1-2), 4–21. https://doi.org/10.1016/j.jmb.2012.02.018
Yang, N. J., & Hinner, M. J. (2015). Getting across the cell membrane: an overview for small molecules, peptides, and proteins. Methods in molecular biology, 1266, 29–53. https://doi.org/10.1007/978-1-4939-2272-7_3
Zhang, J., Ren, L., Wang, Y., & Fang, X. (2019). In silico study on identification of novel MALT1 allosteric inhibitors. RSC advances, 9(67), 39338–39347. https://doi.org/10.1039/C9RA07036B
